Mammography Market Report 2025

The mammography market size has grown rapidly in recent years. It will grow from $2.63 billion in 2024 to $2.89 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to increasing breast cancer incidence, rising awareness and screening programs, government initiatives and funding, advocacy and support groups, improved reimbursement policies.

The mammography market size is expected to see rapid growth in the next few years. It will grow to $4.24 billion in 2029 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to personalized medicine approaches, expansion of breast cancer screening programs, increasing collaboration in research, telemedicine and remote screening, focus on patient-centric care. Major trends in the forecast period include digital mammography dominance, rise of 3d mammography (tomosynthesis), integration of artificial intelligence, increasing emphasis on personalized screening, expanding applications beyond cancer screening, advancements in breast imaging technologies.

The growth of the mammography market is anticipated to be propelled by the increasing incidence of breast cancer. Breast cancer, characterized by the uncontrolled proliferation of cells in the breast, is on the rise globally. Mammography, being a highly influential and widely utilized screening tool, plays a crucial role in the early detection and diagnosis of breast cancer. For instance, in 2023, it is projected that Breastcancer.org, a US-based nonprofit organization, estimates approximately 297,790 new cases of invasive breast cancer and 55,720 new cases of DCIS in U.S. women. The prevalence of breast cancer is evident, as in January 2023, the American Cancer Society reported 287,850 new instances of invasive breast cancer and 51,400 new cases of non-invasive (in situ) breast cancer in the United States for the year 2022. Consequently, the increasing incidence of breast cancer is a driving force behind the growth of the mammography market.

The growth of the mammography market is further fueled by the rising demand for early-stage diagnosis among patients. Early-stage diagnosis involves identifying and detecting diseases at their initial phases, often before noticeable symptoms manifest or the disease progresses. Mammography is integral to early-stage diagnosis due to its capability to detect breast abnormalities, such as tumors or calcifications, at the initial stages. This facilitates timely intervention, leading to improved treatment outcomes by enabling early intervention and reducing the risk of advanced breast cancer development. For instance, in October 2022, the National Health Service (NHS) England reported that more than 100,000 patients received a cancer diagnosis during stages one or two in the past year (2021-2022), representing the largest proportion ever diagnosed at more treatable stages. Hence, the increasing demand for early-stage diagnosis is a significant driver of the mammography market.

Technological advancement is a significant trend gaining traction in the mammography market. Major players in this sector are concentrating on innovative technologies to enhance their market position. For example, in November 2023, GE HealthCare, a U.S.-based healthcare company, launched the MyBreastAI Suite, an advanced AI-powered platform aimed at improving breast cancer detection and optimizing radiology workflows. This suite features three key applications from iCAD, a leader in AI cancer detection, representing a significant leap in breast imaging technology. By incorporating iCAD's AI capabilities, GE HealthCare seeks to enhance clinical decision support, boost diagnostic accuracy, and streamline radiology workflows. This innovation addresses challenges such as increasing imaging volumes and workforce shortages, ultimately contributing to improved patient outcomes. Given that breast cancer is the most frequently diagnosed cancer worldwide, these advancements are crucial for early detection and effective treatment.

Major companies in the mammography market are concentrating on initiatives such as pilot programs to enhance early breast cancer detection, improve patient outcomes, and expand access to underserved populations through mobile screening units and AI-driven diagnostic tools. These efforts aim to increase accuracy, shorten diagnostic times, and make mammography more accessible in remote and economically disadvantaged areas, ultimately promoting better healthcare equity. For example, in December 2023, RadNet, Inc., a U.S.-based healthcare company, launched a pilot program called MammogramNow, which provides mammography services within Walmart Supercenters. This initiative seeks to raise breast health awareness and accessibility by incorporating advanced DeepHealth AI technology into a retail environment, thereby making breast cancer screening more convenient. MammogramNow allows for walk-in appointments, with screenings taking about 15 minutes to complete. Patients also have the option for AI-enhanced screenings through RadNet’s DeepHealth subsidiary to improve detection accuracy. By integrating healthcare services into everyday retail spaces, RadNet and Walmart aim to transform the delivery and accessibility of preventive healthcare in the U.S.

In April 2024, Solis Mammography, a U.S.-based healthcare company, formed a partnership with Northwest Healthcare to enhance breast imaging services in the Tucson area. This collaboration seeks to improve access to essential mammography services, which are vital for early breast cancer detection, particularly for women over 40, who are at greater risk. Northwest Healthcare is also a U.S.-based organization dedicated to delivering high-quality, accessible healthcare to the local community, thereby reinforcing the objectives of this initiative.

Major companies operating in the mammography market include Hologic Inc., Fujifilm Corporation, Siemens Healthcare AG, Canon Medical Systems Corporation, GE Healthcare Company, Metaltronica S.p.A, Koninklijke Philips N.V., Gamma Medica Inc., Konica Minolta Inc., Carestream Health, PLANMED OY, Villa Sistemi Medicali Spa., Toshiba Medical Systems Corporation, Allengers Medical Systems Ltd., Analogic Corporation, IMS Srl, BMI Biomedical International s.r.l., General Medical Merate S.p.A., Genoray Co. Ltd., Agfa-Gevaert N.V., Delphinus Medical Technologies Inc., Micrima Limited, CMR Naviscan Corporation, Dilon Technologies Inc., Koning Corporation, Medi-Future Co. Ltd., PerkinElmer Inc., QView Medical Inc., Radmirtech Co. Ltd., SOREDEX, Trivitron Healthcare Pvt. Ltd., Ziehm Imaging GmbH, Zonare Medical Systems Inc.

North America was the largest region in the mammography market in 2024. The regions covered in the mammography market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mammography market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Mammography serves as a diagnostic X-ray imaging method employed to examine breast tissue for the early detection of malignancies, breast cancer, and other breast ailments. It serves dual purposes as both a screening and diagnostic tool.

Film screen systems, digital systems, analog systems, biopsy systems, 3D systems, and various others constitute the primary types of mammography products. Film screen mammography, a technique within this array, captures images of breast tissue on X-ray film and archives them. This method entails compressing the breast between two plates, subjecting it to X-rays, and developing the resultant image on specialized film.

The mammography market research report is one of a series of new reports that provides mammography market statistics, including mammography industry global market size, regional shares, competitors with a mammography market share, detailed mammography market segments, market trends and opportunities, and any further data you may need to thrive in the mammography industry. This mammography market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mammography market includes revenues earned by entities by screening mammography, diagnostic mammography, digital mammography, and breast ultrasound. The market value includes the value of related goods sold by the service provider or included within the service offering. The mammography market also includes sales of mammography machines, compression paddles and radiographic films. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.